Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 11-2022 | 08-2022 | 05-2022 | 02-2022 | 11-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 940 | 856 | 8,491 | 2,184 | 2,189 |
| Accounts receivable | -725 | 1,211 | 1,011 | -3,040 | 2,508 |
| Accounts payable and accrued liabilities | N/A | -1,823 | 7,095 | -3,258 | 4,722 |
| Other Working Capital | -327 | 2,686 | 10,589 | 69 | 57 |
| Other Operating Activity | -8,132 | -4,126 | -28,333 | -60 | -14,876 |
| Operating Cash Flow | $-8,244 | $-1,196 | $-1,147 | $-4,105 | $-5,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21 | -615 | -305 | -44 | -33 |
| Purchase Of Investment | 0 | -233 | -4 | -2 | -1,142 |
| Sale Of Investment | 3,587 | 5,913 | 406 | 0 | 0 |
| Other Investing Activity | -263 | 92 | 103 | 68 | 101 |
| Investing Cash Flow | $3,303 | $5,157 | $200 | $22 | $-1,074 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 40,000 | N/A | N/A | N/A |
| Debt Repayment | -145 | -28,896 | -154 | -156 | -158 |
| Common Stock Issued | 2,960 | 0 | 0 | 0 | 0 |
| Other Financing Activity | 2,656 | -4,756 | -30 | -1,823 | -5,411 |
| Financing Cash Flow | $5,471 | $6,348 | $-184 | $-1,979 | $-5,569 |
| Exchange Rate Effect | -90 | -93 | -11 | 5 | -4 |
| Beginning Cash Position | 23,416 | 13,200 | 14,342 | 20,399 | 32,446 |
| End Cash Position | 23,856 | 23,416 | 13,200 | 14,342 | 20,399 |
| Net Cash Flow | $530 | $10,309 | $-1,131 | $-6,062 | $-12,043 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,244 | -1,196 | -1,147 | -4,105 | -5,400 |
| Capital Expenditure | -21 | -615 | -305 | -44 | -33 |
| Free Cash Flow | -8,265 | -1,811 | -1,452 | -4,149 | -5,433 |